Who invested in Just Biotherapeutics?
Just Biotherapeutics's investors include Lilly Asia Ventures, ARCH Venture Partners, Gates Foundation, Arch and Merck, and 3 more on record.
China · Series B startup
3 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$64Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Just Biotherapeutics's investors include Lilly Asia Ventures, ARCH Venture Partners, Gates Foundation, Arch and Merck, and 3 more on record.
Just Biotherapeutics has raised $64M across 3 rounds since 2015.
Just Biotherapeutics's most recent round was a Series B of $35M in Jun 2018.
Its most recent round, $35M in Jun 2018, is also its largest on record.
Just Biotherapeutics's first round on record, in Sept 2015, was backed by ARCH Venture Partners, Lilly Asia Ventures and Merck.
Just Biotherapeutics's latest named round is a Series B, in Jun 2018.
Just Biotherapeutics is based in China.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.